Scarica l'app Stockscreener
2.235
1.11%
-0.025
Precedente Chiudi:
$2.26
Aprire:
$2.2689
Volume 24 ore:
17,260
Relative Volume:
0.65
Capitalizzazione di mercato:
$15.71M
Reddito:
-
Utile/perdita netta:
$-7.72M
Rapporto P/E:
-0.8468
EPS:
-2.6394
Flusso di cassa netto:
$-6.25M
1 W Prestazione:
+5.42%
1M Prestazione:
+2.52%
6M Prestazione:
-16.91%
1 anno Prestazione:
-48.26%
Intervallo 1D:
$2.2164
$2.2689
Intervallo di 1 settimana:
$2.10
$2.28
Portata 52W:
$1.55
$5.00
Edesa Biotech Inc Stock (EDSA) Company Profile
Nome
Edesa Biotech Inc
Settore
Industria
Telefono
(905) 475-1234
Indirizzo
100 SPY COURT, MARKHAM, ON
Confronta EDSA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
2.235 | 15.89M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Edesa Biotech Inc Borsa (EDSA) Ultime notizie
Tools to monitor Edesa Biotech Inc. recovery probability2025 EndofYear Setup & Expert Verified Movement Alerts - Newser
Edesa Biotech Inc. stock chart pattern explained2025 Retail Activity & Reliable Trade Execution Plans - Newser
Top chart patterns to watch in Edesa Biotech Inc.Portfolio Risk Report & Intraday High Probability Alerts - Newser
How hedge fund analytics apply to Edesa Biotech Inc. stockTrade Risk Assessment & Consistent Growth Equity Picks - Newser
How to track smart money flows in Edesa Biotech Inc.Market Growth Review & Consistent Profit Focused Trading Strategies - Newser
Real time alert setup for Edesa Biotech Inc. performanceGold Moves & Free AI Powered Buy and Sell Recommendations - Newser
Understanding Edesa Biotech Inc.’s price movementWeekly Trade Review & Weekly Watchlist for Hot Stocks - Newser
How sentiment analysis helps forecast Edesa Biotech Inc.Portfolio Return Report & Low Drawdown Trading Techniques - Newser
Is Edesa Biotech Inc. undervalued by DCF analysisQuarterly Earnings Summary & High Return Trade Guides - sundaytimes.kr
How to build a custom watchlist for Edesa Biotech Inc.Portfolio Risk Summary & Growth Focused Stock Reports - Newser
Can technical indicators confirm Edesa Biotech Inc.’s reversalDip Buying & Short-Term Trading Alerts - Newser
Why is Edesa Biotech Inc. stock going up2025 Valuation Update & Risk Controlled Swing Trade Alerts - thegnnews.com
Edesa Biotech Inc. Included in Top Momentum ScanMarket Risk Summary & Community Consensus Trade Signals - sundaytimes.kr
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Edesa Biotech Inc. Earnings Report Breakdown: What Investors Should Know2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
EDSA: EB06 Manufacturing to be Completed by End of 2025… - Zacks Small Cap Research
Edesa Biotech Inc. Reaches Critical Trendline SupportWall Street Watch & Reliable Price Action Trade Plans - beatles.ru
Can momentum traders help lift Edesa Biotech Inc.Weekly Trade Summary & Free AI Powered Buy and Sell Recommendations - Newser
Edesa Biotech Posts Narrower Loss in Q3 - AOL.com
How Edesa Biotech Inc. stock performs during market volatilitySmart Trade Forecast Based on Neural Logic - Newser
Edesa Biotech: A Narrowing Loss and Strategic Focus Signal Growing Momentum in Dermatology Innovation - AInvest
Will Edesa Biotech Inc. stock go up soonStock Entry Point Planner with Volume Spike - Newser
Edesa Biotech Inc. stock trend outlook and recovery pathShort-Term Bounce Forecast for Oversold Stocks - Newser
How Resilient Is Edesa Biotech Inc. Stock During Economic DownturnsImmediate Entry Point Prediction Strategy - Newser
Edesa Biotech's Strategic Reorientation and Financial Resilience: A Path to Dermatology Sector Growth - AInvest
Edesa Biotech Advances Vitiligo Treatment Amidst Steady Financial Performance - TipRanks
Edesa Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Edesa Biotech Advances EB06 Manufacturing for Vitiligo Study, Reports Q3 2025 Results - AInvest
Edesa Biotech Q3 loss per share narrows - MarketScreener
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results - GlobeNewswire
Edesa's New Vitiligo Drug Manufacturing Progress Signals Path to Phase 2 Trials as Q3 Financials Hold Steady - Stock Titan
Edesa Biotech Inc expected to post a loss of 26 cents a shareEarnings Preview - TradingView
Edesa Biotech EDSA 2025Q3 Earnings Preview Upside Potential on EPS Improvement - AInvest
Edesa Biotech Inc. Ranks High in Smart Money TrackerRisk Controlled Picks With Real Returns Outlined - beatles.ru
Edesa Biotech Inc Azioni (EDSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):